原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征的诊治

杨宁; 刘雁声; 韩英

doi:10.3969/j.issn.1001-5256.2020.03.051

原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征的诊治

DOI: 10.3969/j.issn.1001-5256.2020.03.051

空军军医大学西京医院消化内科

基金项目:

国家自然科学基金项目(81770569,81870421)；

详细信息

中图分类号: R575.7
计量
- 文章访问数: 1495
- HTML全文浏览量: 59
- PDF下载量: 262
- 被引次数: 0
出版历程
- 收稿日期: 2019-11-07
- 出版日期: 2020-03-20

Diagnosis and treatment of primary biliary cholangitis-autoimmune hepatitis overlap syndrome

Department of Gastroenterology,Xijing Hospital,Air Force Medical University

Research funding:

摘要

摘要: 自身免疫性肝病（AILD）包括原发性胆汁性胆管炎（PBC）、自身免疫性肝炎（AIH）、原发性硬化性胆管炎（PSC）。患者可在初诊时或随访的过程中出现2种AILD的特征,通常将这种情况称为"重叠综合征",其中以PBC重叠AIH最为常见。与单纯PBC或AIH相比,PBC-AIH重叠综合征门静脉高压、消化道出血、腹水、死亡及肝移植发生率明显升高,病情进展也更迅速,因此,其早诊早治显得尤为重要。对近年PBC-AIH重叠综合征的诊治进展进行综述。
- 原发性胆汁性胆管炎 /
- 肝炎,自身免疫性 /
- 诊断 /
- 治疗学
Abstract: Autoimmune liver diseases( AILDs) include primary biliary cholangitis( PBC),autoimmune hepatitis( AIH),and primary sclerosing cholangitis. Some patients may have the features of two AILDs at initial diagnosis or during follow-up,which is usually referred to as“overlap syndrome”,among which PBC-AIH overlap is the most common type. Compared with those with PBC or AIH alone,the patients with PBC-AIH overlap syndrome tend to have higher incidence rates of portal hypertension,gastrointestinal bleeding,ascites,death,and liver transplantation,as well as more rapid disease progression,and therefore,early diagnosis and treatment is of great importance. This article reviews the recent advances in the diagnosis and treatment of PBC-AIH overlap syndrome.
- primary biliary cholangitis /
- hepatitis,autoimmune /
- diagnosis /
- therapeutics

HTML全文

参考文献(36)

[1] TRIVEDI PJ,HIRSCHFIELD GM. Review article:Overlap syndromes and autoimmune liver disease[J]. Aliment Pharmacol Ther,2012,36(6):517-533.

[2] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．自身免疫性肝炎诊断和治疗共识(2015)[J]．临床肝胆病杂志，2016,32(1):9-22.

[3] BOBERG KM,CHAPMAN RW,HIRSCHFIELD GM,et al. Overlap syndromes:The International Autoimmune Hepatitis Group(IAIHG)position statement on a controversial issue[J]. J Hepatol,2010,54(2):374-385.

[4] JOSHI S. Primary biliary cirrhosis with additional features of autoimmune hepatitis:Response to therapy with ursodeoxycholic acid[J]. Hepatology,2002,35(2):409-413.

[5] WEILER NC,LOHSE AW. Variant syndromes of autoimmune liver diseases:Classification, diagnosis and management[J]. Dig Dis,2016,34(4):334-339.

[6] LINDOR KD,GERSHWIN ME,POUPON R,et al. Primary biliary cirrhosis[J]. Hepatology,2009,50(1):291-308.

[7] CHAZOUILLÈRES O,WENDUM D,SERFATY L,et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Clinical features and response to therapy[J]. Hepatology,1998,28(2):296-301.

[8] ALVAREZ F,BERG PA,BIANCHI FB,et al. International Autoimmune Hepatitis Group Report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.

[9] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.

[10] European Association for the Study of the Liver. EASL clinical practice guidelines:The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol,2017,67(1):145-172.

[11] EFE C,OZASLAN E,HEURGUE-BERLOT A,et al. Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol,2014,26(5):532-537.

[12] WANG L,HAN Y. An excerpt of primary biliary cholangitis:2018 practice guidance from the American Association for the Study of Liver Diseases[J]. J Clin Hepatol,2018,34(11):2300-2304.(in Chinese)王璐，韩英．《2018年美国肝病学会原发性胆汁性胆管炎实践指导》摘译[J]．临床肝胆病杂志，2018,34(11):2300-2304.

[13] HIMOTO T,YONEYAMA H,KUROKOHCHI K,et al. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases[J]. Can J Gastroenterol,2012,26(3):125-129.

[14] EYRAUD V,CHAZOUILLERES O,BALLOT E,et al. Significance of antibodies to soluble liver antigen/liver pancreas:A large French study[J]. Liver Int,2009,29(6):857-864.

[15] NGUYEN HH,SHAHEEN AA,BAEZA N,et al. Evaluation of classical and novel autoantibodies for the diagnosis of primary biliary cholangitis-autoimmune hepatitis overlap syndrome(PBC-AIH OS)[J]. PLo S One,2018,13(3):e193960.

[16] SCHULZ L,SEBODE M,WEIDEMANN SA,et al. Variant syndromes of primary biliary cholangitis[J]. Best Pract Res Clin Gastroenterol,2018,34-35:55-61.

[17] WANG QX,MA X. Advances in diagnosis and treatment of autoimmune liver diseases overlap syndrome[J]. Chin J Gastroenterol,2018,23(5):283-286.(in Chinese)王绮夏，马雄．自身免疫性肝病重叠综合征诊治进展[J]．胃肠病学，2018,23(5):283-286.

[18] COSS AE,GRANADOS J,URIBE M,et al. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis(AIH-PBC)from those with auto-immune hepatitis type 1?[J]. Ann Hepatol,2011,10(1):28-32.

[19] HIRSCHFIELD GM,KARLSEN TH. Genetic risks link autoimmune hepatitis to other autoimmune liver disease[J]. Gastroenterology,2014,147(2):270-273.

[20] MALIK N,VENKATESH SK. Imaging of autoimmune hepatitis and overlap syndromes[J]. Abdom Radiol,2017,42(1):19-27.

[21] WU H,SHENG L,WANG Q,et al. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome[J]. World J Gastroenterol,2018,24(6):737-743.

[22] CHRISTENSEN E,CROWE J,DONIACH D,et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients[J]. Gastroenterology,1980,78(2):236-246.

[23] KUIPER EM,ZONDERVAN PE,van BUUREN HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome[J]. Clin Gastroenterol Hepatol,2010,8(6):530-534.

[24] ZHANG W,DE D,MOHAMMED KA,et al. New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome[J]. Hepatol Commun,2018,2(3):245-253.

[25] LIU F,PAN ZG,YE J,et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Simplified criteria may be effective in the diagnosis in Chinese patients[J]. J Dig Dis,2014,15(12):660-668.

[26] NEUHAUSER M,BJORNSSON E,TREEPRASERTSUK S,et al.Autoimmune hepatitis-PBC overlap syndrome:A simplifed scoring system may assist in the diagnosis[J]. Am J Gastroenterol,2010,105(2):345-353.

[27] SILVEIRA MG,TALWALKAR JA,ANGULO P,et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis:Long-term outcomes[J]. Am J Gastroenterol,2007,102(6):1244-1250.

[28] YANG F,WANG Q,WANG Z,et al. The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis[J]. Clin Rev Allergy Immunol,2016,50(1):114-123.

[29] PARK Y,CHO Y,CHO EJ,et al. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea:characteristics,treatments,and outcomes[J]. Clin Mol Hepatol,2015,21(2):150.

[30] ZHANG H,YANG J,ZHU R,et al. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome:A meta-analysis[J]. Drug Des Devel Ther,2015,9:567-574.

[31] OZASLAN E,EFE C,HEURGUE-BERLOT A,et al. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis[J]. Clin Gastroenterol Hepatol,2014,12(5):863-869.

[32] WANG Q,SELMI C,ZHOU X,et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis[J]. J Autoimmun,2013,41:140-145.

[33] European Association for the Study of the Liver. EASL clinical practice guidelines:Autoimmune hepatitis[J]. J Hepatol,2015,63(4):971-1004.

[34] CHAZOUILLÈRES O,WENDUM D,SERFATY L,et al. Long term outcome and response to therapy of primary biliary cirrhosis—autoimmune hepatitis overlap syndrome[J]. J Hepatol,2006,44(2):400-406.

[35] BAVEN-PRONK AM,COENRAAD MJ,VAN BUUREN HR,et al.The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes[J]. Aliment Pharmacol Ther,2011,34(3):335-343.

[36] BHANJI RA,MASON AL,MONTANO-LOZA AJ. Liver transplantation for overlap syndrome of autoimmune liver diseases[J]. J Hepatol,2012,56:s89-s90.

施引文献

资源附件(0)

访问统计